The second major contribution of our study to the characterization of ER-/PR+ breast cancer is that we performed an inter-assay reproducibility analysis across two large and diverse breast cancer datasets, in which ER and PR were assessed by multiple methods on the same set of tumors. Here, PGR is linked to breast cancer.